Please login to the form below

Not currently logged in
Email:
Password:

Drug industry forms disaster response group

Rx Response, a programme designed to support the delivery of medicines during a disaster or severe public health emergency, was launched today by healthcare organisations involved in the manufacture, distribution and dispensing of pharmaceutical products

Rx Response, a programme designed to support the delivery of medicines during a disaster or severe public health emergency, was launched today by healthcare organisations involved in the manufacture, distribution and dispensing of pharmaceutical products.

Billy Tauzin, a former US representative from Louisiana, and now president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) said: "During a disaster, it is vital that systems are in place to assist with the continued delivery of medicines to hospitals, healthcare providers and patients in need."

In the past, when the pharmaceutical supply chain was disrupted, there was no single forum for suppliers to convene and share information. Rx Response will expedite information sharing among its partners, community volunteer relief organisations, as well as local, state and federal agencies responding to major disasters.

The partnership includes the American Hospital Association, American Red Cross, Biotechnology Industry Organisation, Healthcare Distribution Management Association, National Association of Chain Drug Stores, National Community Pharmacists Association and PhRMA.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....